Advertisement
Response from Dr. Young

Thanks for your post.
Your reposting of this makes me think that you're looking for a third opinion (one from your doctor and one from Dr. Pierone and one from me). I too am a "aint-broke, don't fix" kinda doctor.
You've been on a simple, highly recommended treatment successfully for the past three years. This means to me that it's highly unlikely that you'll have any issues in the coming years on Combivir and Sustiva. Unless you were having significant untoward symptoms or side effects, or were having difficulty with the twice daily nature of Combivir, I wouldn't be particularly anxious about switching.
While there is a clinical study that demonstrates that up front, persons tend to tolerate Truvada better than Combivir, once accounting for this initial tolerability, there does not seem to be dramatic differences in the two medications, when dosed with Sustiva.
You are correct in that tenofovir and FTC (the two halves of Truvada) are newer medications, and given your situation, I don't think that waiting and watching the developments would be unreasonable.
The real world is the best testing ground for medications-- clinical studies give us an important starting point for thinking about the characteristics of medications. Many newer drugs do provide significant improvements in safety, tolerability or ease of administration. To this extent Truvada does meet many of these goals. However, if you're already doing well on your regimen, I'd continue onward; keep an eye towards the Gilead 934 clinical trial-- it compares the very options that you've listed.
Thanks for reading. BY
|